High-grade carotid artery stenosis: A forgotten area in cardiovascular risk management

Elin Good1, Toste Länne2, Elisabeth Wilhelm2

  • 1Department of Medicine and Health Sciences, Linköping University, Sweden elin.good@liu.se.

Insights

Patients with high-grade carotid artery stenosis face high cardiovascular event rates. Cardiovascular risk management was found to be deficient across all assessed aspects in this patient group.

Area of Science:

  • Vascular Surgery
  • Cardiology
  • Public Health

Background:

  • High-grade carotid artery stenosis (CAS) patients are at elevated risk for cardiovascular (CV) events.
  • The effectiveness of CV risk management in this high-risk population remains largely uncharacterized.

Purpose of the Study:

  • To evaluate the quality of cardiovascular risk management in patients diagnosed with high-grade CAS.
  • To assess CV risk factors, co-morbidities, and outcomes in CAS patients undergoing either carotid endarterectomy (CEA) or conservative management (CM).

Main Methods:

  • A retrospective, cross-sectional study analyzed data from 393 patients with high-grade CAS in Östergötland county, Sweden (2009-2012).
  • Patient data included CV risk management quality, co-morbidities, and 2-year outcomes post-CAS diagnosis, irrespective of treatment (CEA or CM).

Main Results:

  • While prescriptions for antiplatelet agents, statins, and antihypertensives increased post-diagnosis, target levels (e.g., LDL) were unmet in most patients.
  • Lipid levels were not measured in a significant proportion of patients (19.8% CEA, 44.2% CM). HbA1c was also frequently unmeasured in diabetic patients.
  • No documentation of lifestyle counseling (diet, exercise, smoking cessation) was found. The combined clinical event rate was high (36.8% CEA, 36.9% CM) with no significant difference between groups.

Conclusions:

  • Patients with high-grade CAS experience a high rate of clinical events.
  • Current cardiovascular risk management for high-grade CAS patients is inadequate across multiple domains, including medication adherence, target attainment, and lifestyle counseling.
Abstract

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
577
Atherosclerosis IV: Nursing Management01:23

Atherosclerosis IV: Nursing Management

Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...
561
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
839
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
415
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
398
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
441